Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0534 Albicidin
Potent DNA gyrase inhibitor
More description
DCC0533 Alazocine
Potent analgesic, psychotomimetic or hallucinogen, and morphine or opioid antagonist
More description
DCC0532 Ala-vpa Conjugate-1
α-Linolenic acid-Valproic acid conjugate, not only modulating microglia polarization, but also counteracting neurodegeneration and demyelination and induce oligodendrocyte precursor cell differentiation, by acting on multiple biochemical and epigenetic pa
More description
DCC0531 Alalevonadifloxacin Mesylate
Novel anti-MRSA antibacterial agent, targeting infections caused by Gram-positive bacteria
More description
DCC0530 Al-661
Novel HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C
More description
DCC0529 Al-438
Non-steroidal selective modulator for the glucocorticoid receptor (GR)
More description
DCC0528 Al-34662
Potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist
More description
DCC0527 Akti-2
Cell-permeable Akt1/2 inhibitor with improved solubility and Ak2 selectivity
More description
DCC0526 Akr1c3-in-14a
Novel potent and selective aldo-keto reductase 1C3 inhibitor, displaying selectivity for AKR1C3 over other AKR1C enzymes and COX
More description
DCC0525 Akp-11
Novel S1P1 agonist
More description
DCC0524 Akp-001
Novel inhibitor of p38 MAP kinase
More description
DCC0523 Akos024836912
Novel Inhibitor of EGF-EGFR Interactions
More description
DCC0522 Ak963/40708899
Novel and potent PAK1 (p21-activated kinase 1) inhibitor, suppressing the proliferation of human gastric cancer cells significantly by downregulation of PAK1-NFκB-CyclinB1 pathway
More description
DCC0521 Ak346zi
Novel antiproliferative agent
More description
DCC0520 Ajh-836
Novel protein kinase C (PKC) activator, preferentially binding to the novel PKC isoforms PKCδ and PKC∈, stimulated a striking preferential redistribution of PKC∈ to the plasma membrane relative to PKCα, inducing major changes in cytoskeletal reorganizatio
More description
DCC0519 Aj-9677
Novel β3-Adrenoceptor agonist, reducing body fat in obese beagles
More description
DCC0518 Aj-108235
Novel inhibitor of long chain fatty acid elongase 6 (ELOVL6)
More description
DCC0517 Aiu2008
Novel FMS-like tyrosine kinase 3 (FLT3) inhibitor, showing improved anti-leukemic efficacy in FLT3-ITD-positive AML cells, specifically inhibiting cell growth and apoptotic death, down-regulating DNA repair genes involved in homologous recombination and n
More description
DCC0516 Aip-iv
Novel quorum sensing (QS) signaling molecule produced by Staphylococcus aureusagr type IV
More description
DCC0515 Ainsliadimer A
Natural selective inhibitor of IKKα/β by covalently binding a conserved cysteine
More description
DCC0514 Ah-487
Microtubule>Tubulin polymerization inhibitor with marked antitumor activities
More description
DCC0513 Agrocybin
Natural inhibitor of Xanthomonas oryzae growth, against rice pathogens
More description
DCC0512 Agp_a4
Novel Keap1-Nrf2 pathway activator by inhibiting the Keap1 protein
More description
DCC0511 Agp_a3
Novel Keap1-Nrf2 pathway activator by inhibiting the Keap1 protein
More description
DCC0510 Agn-2979 Hydrochloride
Inhibitor of tryptophan hydroxylase activation
More description
DCC0509 Agn-201781
alpha Adrenoceptor agonist for the treatment of neuropathic pain
More description
DCC0508 Agn199108
Inhibitor of the basal proton conductance of UCP1; Retinoid, displaying a nonspecific stimulation of NADH oxidation in control mitochondria
More description
DCC0507 Agn194301
Novel potent and specific RARα antagonist
More description
DCC0506 Agn193836
Retinoic Acid Receptor α Subtype Specific Agonist
More description
DCC0505 Agn193312
Novel potent and selective RARα inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X